Filing Details
- Accession Number:
- 0001641172-25-003364
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-09 12:45:33
- Reporting Period:
- 2025-04-08
- Filing Date:
- 2025-04-09
- Accepted Time:
- 2025-04-09 12:45:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1574094 | Renovorx Inc. | RNXT | Pharmaceutical Preparations (2834) | 271448452 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1862617 | Ramtin Agah | C/O Renovorx, Inc. 2570 W El Camino Real, Suite 320 Mountain View CA 94040 | Chief Medical Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-04-08 | 26,000 | $0.84 | 1,048,460 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Reflects open market purchases of the Issuer's securities.
- The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.825 to $0.8499, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- Includes 975,000 shares, which are held of record by the reporting person currently and were held of record by the Mars16 Nevada Non-Grantor Trust Dtd 01/19/2016 and reported as indirectly held by the reporting person previously.
Billionaire Hedge Funds
